The Role of Octreotide in the Treatment of Gastroenteropancreatic Endocrine Tumors

Publisher： Karger

E-ISSN： 1421-9867|60|2|9-14

ISSN： 0012-2823

Source： Digestion, Vol.60, Iss.2, 1999-04, pp. : 9-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ultra-High-Dose Lanreotide Treatment in Patients with Metastatic Neuroendocrine Gastroenteropancreatic Tumors

By  

Digestion, Vol. 60, Iss. 5, 1999-08 ,pp. : 469-476

Karger

Access to resources Recommend Favorite

The Potential Role of Octreotide in the Treatment of Diabetic Retinopathy

By Grant Maria B.   Sergio Caballero Jr  

Treatments in Endocrinology, Vol. 4, Iss. 4, 2005-01 ,pp. : 199-203

Adis International

Access to resources Recommend Favorite

Role of Octreotide and Somatostatin in the Treatment of Intestinal Fistulae

By  

Digestion, Vol. 60, Iss. 2, 1999-04 ,pp. : 53-56

Karger

Access to resources Recommend Favorite

Neuroendocrine Tumors of the Gastro-Entero-Pancreatic System: The Role of Early Diagnosis, Genetic Testing and Preventive Surgery

By  

Digestive Diseases, Vol. 20, Iss. 1, 2002-07 ,pp. : 49-60

Karger

Access to resources Recommend Favorite

Biological and Molecular Aspects of Gastroenteropancreatic Neuroendocrine Tumors

By  

Digestion, Vol. 62, Iss. 1, 2000-07 ,pp. : 19-26

Karger

Access to resources Recommend Favorite